Abstract: Fruits and vegetables are rich in flavonoids, and ample epidemiological data show that diets rich in fruits and vegetables confer protection against cardiovascular, neurodegenerative and inflammatory diseases, and cancer. However, flavonoid bioavailability is reportedly very low in mammals and the molecular mechanisms of their action are still poorly known. This review focuses on membrane transport of flavonoids, a critical determinant of their bioavailability. Cellular influx and efflux transporters are reviewed for their involvement in the absorption of flavonoids from the gastro-intestinal tract and their subsequent tissue distribution. A focus on the mammalian bilirubin transporter bilitranslocase (TCDB 2.A.65.1.1) provides further insight into flavonoid bioavailability and its relationship with plasma bilirubin (an endogenous antioxidant). The general function of bilitranslocase as a flavonoid membrane transporter is further demonstrated by the occurrence of a plant homologue in organs (petals, berries) where flavonoid biosynthesis is most active. Bilitranslocase appears associated with sub-cellular membrane compartments and operates as a flavonoid membrane transporter.
FLAVONOIDS
Flavonoids are plant-specific secondary metabolites, compounds so named because they are not apparently involved in the survival of the cell. Secondary metabolites are extraordinarily diverse, with upwards of 10 5 structures reported to date, and they are also synthesized at a considerable rate, with approximately 20% of the carbon fixed by photosynthesis dedicated to their biosynthesis [1] . Flavonoids represent one of the largest groups of secondary metabolites, with more than 8000 different compounds described in the literature [1, 2] . Flavonoids are not synthesized in animal cells, thus their detection in animal tissues is indicative of plant ingestion [3] .
Chemistry
The characteristic structural feature common to all flavonoids is a C15 phenylchromane core, composed of a C6-C3-C6 backbone ( Table 1) . The chromane (benzopyran) moiety is composed of 2 condensed rings, an aromatic (benzo) A-ring (C6) and a heterocyclic (pyran) C-ring (C3 associated with another aromatic B-ring (C6). In the majority of flavonoids (flavanols, anthocyanidins, flavanones, flavones, and flavonols) the B-ring is attached at the 2 position, with different subclasses distinguished by the degrees of saturation and oxidation of the C ring ( Table 1) . The relatively uncommon isoflavones are a notable exception to this pattern, where the B-ring is instead attached at the 3 position. Each flavonoid subclass comprises numerous members, differing in the degree of hydroxylation or methoxylation of A and B rings. Additionally, various glycosylation patterns further increase the potential number of flavonoids. In plant cells, flavonoids occur mostly as glycosides, reflecting a biological strategy apparently aimed at increasing their water solubility, at specifying their sub cellular localization and, most likely, at decreasing their propensity to interact with macromolecules.
Occurrence in Food
The main dietary sources of flavonoids are fruits, vegetables, grains and their processed foodstuffs, such as beverages (tea, cof *Address correspondence to this author at the University of Trieste, Department of Life Sciences, via L. Giorgieri 1, 34127 Trieste, Italy; Tel: +390405583680; Fax: +390405583691; E-mail: spassamonti@units.it fee, wine, and beer) and other preserves (syrups, jams, etc.). The flavonoid content in food ranges from 10 to 10 4 mg kg -1 of fresh weight [4, 5] . The most updated database of flavonoid contents in selected foods is compiled by the United States Department of Agriculture (USDA) [6] . Red wines [7] and berries [8] are typically rich in anthocyanins; quercetin, the most common flavonol, is abundant in onions [9] , broccoli and lettuce [10] ; tea leaves, coffee beans and red wine are rich in flavanols [11] ; soybeans are rich in isoflavones [12] ; citrus fruits are rich in flavanones [13] , while tropical plants are also rich in flavonoids [14] . Consistently, the World Health Organization (WHO) recommends, together with physical activity, a daily intake of at least 400 g of fruit and vegetables, expected to save up to 2.7 million lives annually through the prevention of cardiovascular diseases, certain cancers, obesity and diabetes [27] .
Cellular and Molecular Targets
Flavonoids have gained celebrity because of their well demonstrated in vitro antioxidant activity [28] . Since many chronic diseases and ageing phenomena result from an imbalance between the production of reactive oxygen species and our anti-oxidant defenses [29, 30] , this antioxidant activity was regarded as the main biological activity of flavonoids for many years. However, this idea is challenged by bioavailability data, showing that the concentration in plasma and organs for most flavonoids following oral ingestion was in the nM-to-M range [31] , and thus far below a reasonable threshold of antioxidant efficacy. Additionally, the impact of flavonoid intake on plasma antioxidant capacity has been recently questioned, since intake of flavonoids is usually accompanied by the intake of fructose. Intracellular conversion of fructose to fructose 1-phosphate leads to a temporary depletion of ATP in the liver, and ultimately catabolism of AMP to urate, which can explain observed changes to the antioxidant capacity of plasma following fruit intake [32] . Other possible interferences on endogenous cellular antioxidants by flavonoids are discussed below in sections 4.1.2 to 4.1.4.
Alternative mechanisms for the complex cellular responses elicited by flavonoids are required. In particular, the bioactivity of flavonoids must be characterized in terms of specific interactions with molecular targets [33] . It has been recently shown that flavonoids interact with enzymes involved in cell signaling cascades [34] , most of which are ATP-binding proteins. Flavonoids inhibit ATP binding to many kinases [35] , resulting in a variety of cellular effects, encompassing modulation of neuronal function [36, 37] , cancer cell proliferation [38, 39] , and inflammation responses [16, 40, 41] . Control of inflammation by flavonoids may be mediated via inhibition of lipoxygenases and cycloxygenases, resulting in a decreased production of both inflammation mediators (leukotrienes and prostaglandins) and reactive oxygen species [33] . The direct interaction of isoflavones with estrogen receptors has also been investigated in the frame of dietary control of prostate and breast cancer [42] .
It is also important to mention that flavonoids interact with various drug-metabolizing enzymes, including cytochrome P450 monooxygenases and phase II conjugation enzymes, as well as primary active drug transporters involved in drug excretion [43] [44] [45] . Such multi-step interactions may explain drug-diet interactions that have not yet been properly elucidated.
In conclusion, flavonoid bioactivities appear to be quite broadspanning. Hence, it is worth questioning whether the very low oral bioavailability of flavonoids may represent the first and the most essential line of mammalian defense against such a vast potential of molecular interactions, especially with intracellular enzymes involved in key functions such as the cell cycle.
Bioavailability
Bioavailability refers to the proportion of a substance which reaches systemic circulation unchanged, after a particular route of administration 1 , which, as far as dietary flavonoids are concerned, is obviously the oral one. Such a route involves transport across the gastro-intestinal epithelium. Under normal conditions, the intestinal epithelium exists as a single layer of tightly connected cells, so that a continuous barrier is formed. If the intercellular junctions are disrupted, as happens in certain intestinal diseases, paracellular transport of water and solutes can occur [46] . Enterocytes are polarized cells, with one pole facing the lumen, (the compartment where food is processed for absorption), whereas the opposite pole is in contact with the blood capillaries. Thus, in essence, there are two plasma membrane barriers for solutes to overcome, both the apical (luminal) and the basolateral (vascular) membranes, as shown in Fig. (1) . These barriers ensure selective uptake and exchange of material between the environment and the body, and form the basis of cellular homeostasis. As a result of the long history of evolutionary adaptation by organisms to their environment, intestinal cells express a wide battery of membrane proteins that control the transepithelial transport of dietary compounds [47] . This complexity challenges the delivery of newly developed drugs via oral administration, and requires the elaboration of adequate drug permeability predictive models. According to the rule-of-five prediction model, compounds with relative molecular mass > 500 and prone to form hydrogen bond interactions are generally unable to cross biological membranes by passive (i.e. not carrier-mediated) diffusion [48] , and thus dietary flavonoids have little, if any, chance to be passively absorbed at the gastro-intestinal level. This is indeed confirmed by a number of studies, showing that flavonoid bioavailability is mostly <1% of the administered dose [31] . Furthermore, outside of the gastrointestinal tract, all other cell plasma membranes provide additional barriers to flavonoid diffusion into peripheral tissues. 1 COT glossary of terms (http://cot.food.gov.uk/moreinfo/cotglossary),p:// cot.food.gov.uk/moreinfo/cotglossary).
Fig. (1).
Scheme of plasma membrane transport systems in an epithelial cell. The apical (A) and the basolateral (BL) plasma membrane domains, facing the lumen and the blood system respectively, express ATP-dependent pumps (1), uniporters (2), symporters (3) and antiporters (4).
The stringent control of the intestinal membrane transport of flavonoids is achieved by a coordinated function occurring at the cell plasma membrane level. It appears that most nutrient-specific influx membrane transporters, (those promoting nutrient absorption), are unable to transport flavonoids, while various multispecific efflux transporters, (those using metabolic energy to pump drugs and xenobiotics out of cells), in fact, recognize flavonoids, and therefore actively contribute to their extrusion and excretion.
MEMBRANE TRANSPORT OF FLAVONOIDS 2.1. General Principles of Membrane Transport
The plasma membrane is the supra molecular structure that ultimately delimits the cell, the fundamental unit of life. A controlled flow of molecules takes place across this membrane, due to the activity of tightly regulated and highly-specific transport proteins. Indeed, it has been recently found that even gases such as carbon dioxide [49] and ammonia [50] , previously believed to passively move across membranes by virtue of their ability to dissolve in hydrophobic environments, instead diffuse via specific channels, occurring on the plasma membrane of cells, via proteins conserved across all three kingdoms of life.
Transport proteins can act as channels, pumps or transporters [51] , as shown in Fig. (1) . Channels operate as specific pathways for the rapid permeation of ions moving down an electrochemical gradient. Pumps are membrane proteins that actively transport molecules against their electrochemical gradient at the expense of a cellular source of energy, such as ATP. Pumps are also referred to as primary active transporters. Their protein structure comprises an ATP Binding Cassette (ABC) with a conserved consensus sequence(s), where ATP binding and hydrolysis occurs [52] .
Transporters are solute carriers (SLC), which promote the transmembrane movement of molecules without hydrolyzing ATP. If only a single type of molecule is transported down an electrochemi-cal gradient, it is classified as a uniporter, while if it moves two molecules at the same time in either the same or in opposite directions, it is named a symporter or antiporter, respectively. These cotransporters may mediate secondary active transport by coupling the movement of one solute against its electrochemical gradient with the downhill transport of the co-transported species; often the latter is an ion, like sodium or calcium, whose intracellular concentration is maintained orders of magnitude lower than that outside the cell, by primary active transporters like sodium and calcium pumps.
From a functional point of view, membrane transport proteins are very similar to enzymes, in that they specifically bind their transport substrate(s) by establishing a network of weak chemical interactions at the level of their transport site; substrate translocation from one side of the membrane to the other occurs by a coordinated sequence of protein conformational transitions; substrate binding and transport can be competitively or non-competitively inhibited by other structurally similar molecules able to fit into or close to the transport site; and protein modifying reagents can cause loss of transport function by binding to functionally sensitive regions of the transporters.
Influx and efflux transporters move solutes either into or out of cells. In absorptive epithelial cells lining the intestine, nutrient influx transporters may be uniporters located at the apical (luminal) domain of the cell, facilitating the diffusion of solutes until an electrochemical equilibrium is established across the membrane; a typical example is the facilitated glucose transporter GLUT2 (SLCA2) [53] . Other influx transporters are symporters (e.g. the sodiumcoupled glucose transporter 1, SGLT1 or SLC5A1 [54] ), which couple the movement of nutrients to that of ions, providing a driving force to accumulate nutrients within the cell. Various intestinal transporters mediate co-transport of sodium (or proton) and microor macro-nutrients into the cell, and various drugs are absorbed via these mechanisms [55] . Solute efflux from cell cytoplasm might be facilitated by solute carriers, but often the efflux is efficiently mediated by primary active transporters.
Pumps Involved in Cellular Efflux of Flavonoids
The cellular efflux of flavonoids is better known than their influx and various reviews cover this topic [56] [57] [58] . In fact, various flavonoids have been found to interact with ABC transporters, mainly P-glycoprotein (ABCB1), the Multidrug Resistanceassociated Proteins MRP1 (ABCC1), MRP2 (ABCC2) and the Breast Cancer Resistance Protein BCRP (ABCG2) [59] . These transporters are characterized by loose substrate specificity and are involved in limiting the access of non-nutrient compounds to cells. In polarized cells, like the enterocytes, ABC pumps occur in both the luminal and the basolateral plasma membrane domains, and promote efflux of substrates at both sides. These ABC pumps are key players in cancer drug resistance, as they pump drugs (chemotherapy agents) and general xenobiotics out of the cells. By interacting with ABC pumps, flavonoids may interfere with the cellular efflux of cancer drugs and may therefore be used as adjuvant in cancer therapy [60] .
Transporters Involved in Cellular Influx and Efflux of Flavonoids
Much is still unknown about membrane transporters involved in the gastro-intestinal absorption and tissue distribution of flavonoids, and the available knowledge is presented below. Most transporters are endowed with rather loose substrate specificity, as they transport not only endogenous molecules but also many drugs and xenobiotics, even those that are not based on naturally occurring compounds [61] . Understanding the structure, function and specificity of membrane transporters is regarded as a critical step in predicting oral drug bioavailability, tissue targeting and efficacy [62] . The same holds for flavonoids. This review section is aimed at giving an overview on membrane transporters involved in the cellular influx and efflux of dietary flavonoids which may also give origin to flavonoid-drug interactions [63] .
Glucose Transporters
In addressing this issue, it must be noted that most flavonols and isoflavones occur in the diet as glycosides [4, 64] . In the intestinal lumen, they undergo de-glycosylation by lactase-phlorizin hydrolase (EC 3.2.1.108), a disaccharidase located on the epithelial surface, and the released aglycones are transported into the intestinal cells, where they are again conjugated, mainly to glucuro-and sulpho-derivatives [64] . However, it has been suggested that quercetin glycosides are absorbed intact across the intestine via glucosespecific transporters [65, 66] .
The major intestinal glucose transporters are the sodiumdependent glucose transporter SGLT1 (SLC5A1), located apically (i.e. facing the lumen), and the facilitative transporter GLUT2 (SLC2A2), located both apically and basolaterally [67] . The isoform SGLT1 has been regarded as a specific carrier for some quercetin glycosides [66, [68] [69] [70] . Although some data are controversial [71] , SGLT1-mediated transport of flavonoids, including phlorizin, was indeed shown in SGLT1 transfected cell lines, although this was only possible when flavonoid efflux transporters (MRP1 and MRP2) were inhibited and, under these conditions, the influx rate prevailed over the efflux [72] . Also, GLUT2 has been reported to transport quercetin 3-glucoside in Caco-2 cells and in basolateral membrane vesicles [73] . Confusion around these results increased with the observation that, in transfected cells, flavonoids inhibit (though are not transported by) GLUT2, but not SGLT1 [74, 75] . Using a different transport assay applied to transfected cells, flavonoids were again found to inhibit, but not to be transported by SGLT1 [76] .
The transporter GLUT4 (SLC2A4), a major effector of insulinmediated glycaemic homeostasis and expressed in adipose and muscle cells, was found to be not only inhibited by genistein [77] , myricetin, quercetin and catechin-gallate, but was also able to transport them [78] . Another ubiquitous, high-affinity and lowcapacity facilitative glucose transporter, GLUT1 (SLC2A1), has been reported to transport quercetin [79, 80] .
Many inconsistencies reported in the literature might be ascribed, in part, to the unavoidable limits of the experimental in vitro models employed. Indeed, in vivo data do suggest that the rate of intestinal glucose absorption is possibly regulated by flavonoids [81] [82] [83] [84] [85] , in line with the famous hypoglycaemic effect of the flavonoid phlorizin [86] . Such modulation is extremely promising, since flavonoids might thereby lower the peak of post-prandial blood glucose (glycaemic index) and, therefore, positively modulate the dependence on insulin, whether in health or in pre-and diabetic conditions [87] . By contrast, bearing in mind that glucose is a principal substrate for cellular oxidative metabolism coupled to ATP synthesis, it is not surprising that the molecular architecture of glucose transporters must ensure an essentially undisturbed flux of glucose from the intestine into the blood and cells even in the presence of plant secondary metabolites.
Monocarboxylate Transporters
The monocarboxylate transporter (MCT, SLC16) family includes 14 members; four of them (MCT1-4) have been shown to catalyze the proton-coupled transport of low molecular weight monocarboxylates important in intermediate metabolism, such as lactate, pyruvate and two ketone bodies [88] . In addition, they also transport drugs of common use [89] .
MCT1, one of the best characterized in the family and occurring nearly ubiquitously [90] , is involved in the transport and disposition of gamma-hydroxybutyrate, a psychotropic drug. This transport is potently inhibited by various flavonoid aglycones, as demonstrated in vitro [91] , and in vivo for luteolin [92] . Nonetheless, direct MCT-mediated uptake of flavonoid aglycones has been ruled out [91] . Flavonoid inhibition of MCT1 has also been reported in the intestinal-type Caco-2 cells [93] , and evidence suggests the family member MCT2 is inhibited by flavonoids as well [88] .
Organic Anion Transporters
Organic anion transporters (OAT, SLC22A family) are found in kidney, liver, eyes and brain [94] . In the kidney, they catalyze the membrane transport of various endogenous and exogenous organic anions, thus playing an important role in their urinary excretion [95] . Morin and silybin have been characterized as both inhibitors and substrates of hOAT1 (SLC22A6) [96] . Since various nephrotoxic drugs used in antiviral and anticancer therapies are taken up from the blood into the kidney via OAT1, these flavonoids, (morin and silybin), could serve to slow down the drug's elimination rate, thereby allowing for decreased therapeutic dosages and reduced nephrotoxicity [96] .
Organic Anion Transporting Polypeptides
Similarly to OATs, organic anion transporting polypeptides (OATP, SLCO/SLC21 family) mediate the sodium-independent uptake of a wide range of endo-and xenobiotics, including drugs; they are expressed in many tissues, such as the blood-brain barrier, choroids plexus, lungs, heart, intestine, liver, kidneys, placenta and testes [97] . While lacking significant sequence homology with OATs, these organic anion transporting polypeptides possess similar and overlapping substrate specificities. Fruit juices have been shown to inhibit OATP-mediated drug uptake at the level of the intestine [98] [99] [100] . A more recent study assessed the inhibition of OATP1B1 (SLCO1B1) by various flavonoids [101] , but since no evidence of their transport was obtained, flavonoids are considered modulators rather than substrates of this carrier.
Other
No interactions of flavonoids with other classes of transporters, such as amino acid transporters (belonging to multiple SLC families) [102] , nucleoside transporters (SLC 28 and SLC 29 families) [103] , peptide transporters (SLC 15 family) [104] , organic cation (SLC 22A1-3) or carnitine (SLC 22A4-5) transporters [105] have been reported.
BILITRANSLOCASE AS A MAMMALIAN FLAVONOID TRANSPORTER
Bilitranslocase is a membrane protein originally isolated from rat livers [106, 107] . Its transport function has been reconstituted in both liposomes [108] and erythrocyte plasma membrane vesicles [109] using the synthetic dye bromosulfophthalein (BSP) as a transport substrate, indicating it functions as a uniporter.
Bilitranslocase Transport Activity Assay
The transport activity of bilitranslocase has been largely characterized in rat liver plasma membrane vesicles [110, 111] . The functional assay consists of the real-time spectrophotometric recording of BSP concentration in the medium external to the vesicles. BSP is a pH-dependent tautomeric molecule, occurring as either a protonated and colorless phenolic species at neutral pH or as a deprotonated purple quinoid form under more basic conditions (A max =580 nm), as shown in Fig. (2) . The transport activity assay is designed so that the intra-and the extra-vesicular compartments are buffered at pH 7.2 and 8.0, respectively, with only the extravesicular buffer containing K + . In principle, under such experimental conditions, any movement of BSP from the extra-vesicular medium into the vesicular compartment will cause its protonation and decoloration and, consequently, a drop of the absorbance at =580 nm. The resulting change in absorbance is corrected by simultaneous recording of the baseline turbidity of the vesicle suspension at =514 nm.
Upon addition of plasma membrane vesicles to the assay medium, an instantaneous drop in the signal (A 580-514 ) is observed. This is a complex phenomenon, explained by both entry of the dye into vesicles and its adsorption to vesicle phospholipids. Once the resulting optical signal is stable, representing a trans-membrane electrochemical equilibrium and saturation of any non-specific adsorption to the membranes, BSP transport is triggered through the addition of valinomycin. This macrocyclic dodecapeptide is a K + -specific ionophore and its nearly instantaneous insertion into the membrane makes the latter permeable to extra-vesicular K + . This generates a membrane potential (positive inside), that provides a supplementary electrophoretic force driving BSP movement into the vesicles. This valinomycin-induced BSP movement is referred to as electrogenic BSP transport, and its initial rate depends on both the plasma membrane enrichment of the preparation and the magnitude of the electrical potential imposed to the membrane [110] . Additionally, this rate depends on the concentration of BSP in the medium, and follows Michaelis-Menten kinetics, with K m of about 5 M [112] [113] [114] . Based on evidence obtained by using specific monoclonal antibodies targeting purified bilitranslocase [111] , the electrogenic BSP transport activity in rat liver plasma membrane vesicles was ascribed to bilitranslocase. Kinetic data also indicate this assay is strictly specific for bilitranslocase [113] , making it a valuable tool for screening its substrate specificity.
Fig. (2)
. Tautomeric 3D structures of bromosulfophthalein (above) and thymol blue (below). Upon protonation, their quinoidal planar structures (left) convert to the phenolic tetrahedral ones (right). 3D structures were generated by ACD/ChemSketch 10.0 freeware. 2D phenolic tautomers are also displayed in Table 2 .
Tautomer-Specific Phthalein Transport by Bilitranslocase
Thymol blue is another pH-indicator phthalein, shown in Fig.  (2) . Unlike BSP, which occurs either as a tri-or a di-anion, only the quinoidal tautomer of thymol blue is charged, and is thus mobile in an electric field. Thymol blue is transported electrogenically in rat liver plasma membrane vesicles [112] , indicating the carrier substrate is the quinoidal tautomer. Indeed, the quinoidal tautomer of BSP also appears to be the exclusive species undergoing electrogenic transport into vesicles, since the phenolate species accumulates in the more acidic intra-vesicular compartment, indicating the plasma membrane is essentially impermeable to this form [110] . This fact is essential to understanding and predicting the interaction between bilitranslocase and its substrates. The quinoidal tautomer of phthalein is essentially a planar molecule, unlike the phenolic form, and thus it has been concluded that planarity is a structural requisite of bilitranslocase substrates. This principle has also been confirmed through studying the interaction of bilitranslocase with flavonoids [115] (see below section 3.4.2). Indocyanine Green Indoles 
Bilitranslocase-Specificity of Electrogenic Bromosulfophthalein Assay
The electrogenic transport of both BSP and thymol blue into rat liver plasma membranes is competitively inhibited by the tetrapyrrolic bile pigment bilirubin [112] and its precursor biliverdin [116] ( Table 2) , and this same inhibition can be observed in membrane vesicles obtained from the human hepatocyte cell line HepG2 [117] . Bilirubin is synthesized by the enzyme biliverdin reductase (EC 1.3.1.24) [118] from biliverdin, a tetrapyrrole derived from oxidative cleavage of heme via the ubiquitous enzyme heme oxygenase (EC 1.14.99.3) [119] . Bilirubin is normally found in blood, taken up by the liver, and ultimately excreted into the bile. The relationship between BSP and bilirubin is discussed below in section 4.1.1.
A number of other organic anion membrane transporters such as OATPs and OATs [120] also occur in the liver plasma membrane, each potentially capable of electrogenic uptake of BSP into vesicles. However, electrogenic BSP transport is not inhibited by typical OATP or OAT substrates, such as taurocholate [112, 117] , digoxin [117] , ouabain or salicylic acid (unpublished data), indicating that tautomeric-specific electrogenic transport of phthaleins is a functional signature of bilitranslocase.
Inhibition of Bilitranslocase Transport Activity by Flavonoids

Anthocyanins as Phthalein Mimetics
In the search for potential natural products substrates for bilitranslocase, with structural similarities to BSP, the focus was initially put on anthocyanins. Anthocyanins display some chemical and structural analogies with phthaleins, such as a planar system of conjugated aromatic rings and pH-dependent tautomerism, through protonation of quinoidal species resulting in a conversion to phenolic ones [121] . The term anthocyanin refers to glycosides of poly-hydroxy and polymethoxy derivatives of flavylium (or 2-phenylbenzopyrylium) salts. The aglycone bodies of anthocyanins are called anthocyanidins, the most common ones being pelargonidin, cyanidin, petunidin, peonidin, delphinidin, and malvidin ( Table 1 ) [122] . Their interactions with bilitranslocase were examined through inhibitory activity of electrogenic BSP transport into rat liver plasma membrane vesicles [114] . Seventeen out of twenty anthocyanin compounds tested behaved as competitive inhibitors (K i =1.4-22 M), with the strongest inhibition displayed by the mono-and di-glucoside derivatives. These results revealed an unsuspected feature of the bilitranslocase transport site(s), that is, to be a very precise recognition mechanism for sugar moieties. Interestingly, minor variations to the pyranose sugar ring, particularly at carbons in the 4 and 5 positions, are associated with a switch from competitive to non-competitive inhibition.
Flavonols vs. Anthocyanins
A battery of flavonols, (7 different aglycones, 7 differently glycosylated quercetin derivatives and 8 glycosylated derivatives of other aglycones), were also tested for inhibition capacity. Surprisingly, only three aglycones were found to be inhibitors of electrogenic BSP uptake into rat liver plasma membrane vesicles, i.e. galangin (non-competitive inhibitor, K i =61 M), kaempferol (a mixed-type inhibitor, non-competitive K i =64 M, competitive K i =132 M), and quercetin (a mixed-type inhibitor, non-
To understand the different interactions between anthocyanins and flavonols with the carrier, a quantitative structure-activity evaluation, based on counter propagation artificial neural network modeling was undertaken [115, 123] . The first step was to categorize the tested molecules into three classes of activity: inactive molecules, competitive inhibitors, and non-competitive inhibitors. The aim was to segregate the molecules into activity clusters lying on a bi-dimensional grid (the Kohonen map). Clustering was finally obtained using 155 molecular descriptors, selected automatically by a computational procedure based on a genetic algorithm. Such classification was further validated by testing the predictive accuracy of the model. The automatically-selected molecular descriptors characterize the ability of target molecules to interact with bilitranslocase via hydrogen bonds, thereby shedding light on the hydrophilic properties of the active site of bilitranslocase. Importantly, none of the selected molecular descriptors include electric charges, suggesting the (anionic) inhibitors do not bind to the carrier via electrostatic interactions. Indeed, displaying their negative charge is an essential requirement for electrogenic movement along the translocation pathway.
Certain structural elements of flavonols might explain their lack of or mixed-type inhibition on bilitranslocase BSP transport function. The lack of inhibition is reasonably explained by the C4 carbonyl on C ring, with the resulting steric hindrance acting in two ways. As shown by an optimized 3D structure of quercetin 3-glucoside [115] , the C4 carbonyl forces the 3-glucosyl moiety to be perpendicular to the plane of the flavonol aglycone, making quercetin 3-glucoside non-planar and essentially inactive. Its anthocyanin homologue, cyanidin 3-glucoside, possessing a sugar moiety which is co-planar with the aglycone, is one of the best competitive inhibitors (K i =5.8 M), confirming the idea that bilitranslocase ligands are essentially flat. Additionally, myricetin, possessing full hydroxylation of B ring (3',4',5'-trihydroxyphenyl), is an inactive aglycone, in contrast to its anthocyanin homologue delphinidin, which is the most active of the anthocyanin aglycones (K i =5.3 M), again showing the incompatibility of the flavonol C4 carbonyl groups with bilitranslocase.
Mixed-type inhibition by flavonol aglycones apparently stems from the capacity of flavonols to interact with two kinetically distinguishable sites in bilitranslocase, selectively accessible by two pH-dependent tautomers of flavonols. The quinoidal, anionic tautomer occupies the competitive inhibition site, whereas the neutral phenolic one binds the non-competitive site, evidenced by the effect of galangin, a flavonol aglycone with a phenylic B ring incapable of shifting to a quinoidal tautomer, and instead acts as a pure non-competitive inhibitor. Applying this theory to anthocyanins, pure competitive inhibition indicates that only their quinoidal tautomers are active, while their phenolic tautomers are incapable of binding the non-competitive inhibition site, perhaps because they are cationic. A direct physiological implication of this principle may be seen in the acidic compartments delimited by bilitranslocase-expressing membranes, the central vacuole of plant cells being an example (see below section 5.2) [116] , which apparently serves as a sink for the accumulation of anthocyanins.
Other Flavonoids
Other flavonoids, such as the flavanol (+)-catechin and some isoflavones (genistin, genistein, daidzin, daidzein and puerarin), do not act as bilitranslocase inhibitors (S. Passamonti, unpublished data). Further studies are required for a complete overview on the interaction of bilitranslocase with other flavonoid sub-classes.
Implications
Based on these data and other evidence concerning bilitranslocase-mediated uptake of anthocyanins into cells (see section 3.7 below), bilitranslocase can be thought of as an exquisite, anthocyanin-specific transporter, since other flavonoids are not effective ligands. An interesting outcome of these investigations is the unexpected discovery that bilitranslocase can interact with glucosyl moieties. In the case of anthocyanins, the drastic increase of overall polarity conferred by the glucosyl moieties increases the strength of the interaction [114, 115] . Unlike flavonols and isoflavones, anthocyanin aglycones possess a unique flavonoid scaffold for orienting the bound glucosyl moieties in a manner crucial in determining both the strength and type of interaction with bilitranslocase. It can be postulated that a sugar moiety may actually serve as a tag to address a compound to bilitranslocase. This property may gain further importance when considering that bilitranslocase is expressed in the gastro-intestinal epithelium, where it may contribute to the oral bioavailability of anthocyanins or other micronutrients and drugs.
The Primary Structure of Bilitranslocase
The primary structure of bilitranslocase has been deduced from the nucleotide sequence of a cDNA clone isolated from a rat liver cDNA expression library. The strategy for cDNA cloning is described in some details, because it yielded an unexpected transcript. Cloning was not based on hybridization with probes derived from predefined or predicted gene sequences, and its nucleotide sequence showed an unexpected homology with a transcript from the opposite DNA strand. The experimental validation of the cDNA nucleotide sequence is also presented in detail, since it may be taken as a not really common example of testing the structure and function of a protein in complex systems, rather than in isolation.
Strategy and Output of Cloning
A monoclonal antibody, capable of both reacting with a protein under denaturing conditions and inhibiting the electrogenic BSP uptake in rat liver plasma membrane vesicles, was developed as a cloning tool [124] . This approach was expected to ultimately yield the entire nucleotide sequence of the rat liver electrogenic BSP transporter. However, the cDNA obtained from an immuno-positive clone, hereafter referred to as bilitranslocase cDNA, was found to be truncated, thereby preventing its use in expression systems. Nevertheless, its validation was carried out by both computational and experimental approaches.
Computational Validation of Bilitranslocase cDNA
Bilitranslocase cDNA displayed an open-reading frame at the 5' end, suggesting it could be translated, and the predicted amino acid sequence yielded no significant large-scale homology to other known proteins. At a smaller scale however, a short segment of bilitranslocase primary structure (amino acids 58-99) matched very well to a highly conserved protein segment (amino acids 6-45) of the -chain of phycocyanins [124] . This is of considerable biological importance, since the prosthetic group of phycocyanins is phycocyanobilin, a tetrapyrrole structurally similar to biliverdin, the metabolic precursor of bilirubin in mammalian cells. Available crystallographic analysis indicated that phycocyanobilin is in close contact with the highly conserved segment encompassing amino acids 6-45 of a phycocyanin -chain [125] .
Experimental Validation of Bilitranslocase cDNA
The nucleotide sequence of the partial bilitranslocase cDNA clone (Section 3.5.1) was used in a RACE-PCR approach to generate the full-length cDNA (EMBL Accession No. Y12178) [124] , from mRNA isolated from rat liver cytoplasm, thereby validating bilitranslocase expression within rat livers. The complete bilitranslocase nucleotide sequence comprises 1026 base pairs and encodes for a 38.22 kDa protein of 340 amino acids. To validate that bilitranslocase cDNA could be successfully translated, antibodies were raised against a synthetic peptide corresponding to segment [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] (encompassed in the domain that is highly conserved inphycocyanins). As detailed below, this antibody reacted with purified bilitranslocase and specifically inhibited electrogenic BSP uptake in rat liver plasma membrane vesicles [124] .
Based on these experiments, bilitranslocase has been included in the Transporter Classification Database (http://www.tcdb.org/), which is approved by the International Union of Biochemistry and Molecular Biology (IUBMB) [126] , and complements the Enzyme Classification System. Due to its unique primary structure, bilitranslocase is encoded as entry TCDB #2.A.65.1.1, the first reported member of a unique transporter family.
Features of Bilitranslocase-Ceruloplasmin Sense-Antisense Overlapping
A very unusual and unexpected feature of the bilitranslocase nucleotide sequence (1026 base pairs) is its 94% homology to a portion of the antisense strand of ceruloplasmin gene.
Ceruloplasmin (EC 1.16.3.1) is a well-known plasma glycoprotein, which incorporates over 95% of the copper present in the blood of all vertebrate species [127] , and which is involved in many biological processes [128] , mainly because of its cuprooxidase activity [129] . It also plays a role in iron metabolism, where as ferroxidase, it mediates the copper-mediated conversion Fe 2+ Fe 3+ , required to load Fe 3+ onto the apotransferrin [130, 131] . Ceruloplasmin is homologous to other multicopper oxidases, such as Neurospora crassa laccase (EC 1.10.3.2) and ascorbate oxidase (EC 1.10.3.3) from cucumber (Cucumis sativus) [132] . Bilitranslocase mRNA shares homology with ceruloplasmin antisense mRNA at its 3'-end, including part of the 3'-UTR (untranslated region). Structurally, ceruloplasmin is a 1046 amino acid single chain protein with an internal triplication in its primary structure [133] . Evidence suggests an ancestral tandem gene triplication took place. In the human genome a ceruloplasmin-processed pseudogene, (corresponding to exons of the carboxy-terminal residues plus the 3'-untraslated region of the functional gene), has also been isolated and characterized [134] . The human ceruloplasmin-gene has been mapped on chromosome 3q23-q24 [135] , whereas the pseudogene has been localized in chromosome 8q21.13-q23 by in situ hybridization [136] . In humans, bilitranslocase may be derived from the antisense transcript of either the functional gene or the pseudogene. Before the publication of the mammalian transcriptome [137, 138] , antisense transcription was seen as artefacta, mainly because it violated an oversimplified model of the gene [139] . Although their biological meaning remains elusive [140] , many antisense RNAs (also called natural antisense transcripts, NAT) are related to the regulation (either concordant or discordant) of the corresponding sense gene expression [141] [142] [143] [144] , and changes in their transcription rate have been implicated in the pathogenesis of cancer and neurological diseases [145] .
Very recently, the sense/antisense pairs of diverse organisms have been systematically assembled into specific databases [anti-CODE (http://www.anticode.org) [146] and NATsDB [147] (http://natsdb.cbi.pku.edu.cn). According to the antiCODE database -which contains more than 30000 non-redundant entries from 12 eukaryotic model organisms-most of the NATs are non-coding RNAs, while 30% of pairs are composed by coding/coding overlapping transcripts. Bilitranslocase/Ceruloplasmin is reported as entry RNO 30106 [antiCODE pair number].
Anti-Sequence Bilitranslocase Antibodies
For the experimental validation of bilitranslocase cDNA, three anti-sequence antibodies have so far been produced, referred to as antibody A, antibody B and antibody C. 3.5.5.1. Antibody A Antibody A was raised against a synthetic peptide corresponding to segment 65-75 of the predicted amino acidic sequence of bilitranslocase; said segment is highly homologous to a consensus sequence embedded in the 6-45 segments of phycocyanin -chains (see Section 3.5.2, above). This antibody revealed at least 6 highly relevant biological activities, by reacting with: i) the protein expressed in the cloned E. coli colony [124] , ii) a single protein in rat liver microsomes separated by SDS-PAGE electrophoresis [124] , iii) the purified rat liver bilitranslocase [124] and by inhibiting: iv) the BSP electrogenic uptake in rat liver plasma membrane vesicles [124] , v) the BSP electrogenic uptake in microsomes obtained from HepG2 cells (derived from a human hepatocarcinoma) [117] , and vi) the uptake of bilirubin and BSP into HepG2 cells [117, 148] .
Each of these pieces of experimental evidence supports the expression of a protein bearing the selected epitope. Use of this antibody is particularly valuable as it inhibits substrate transport not only in plasma membrane vesicles, but also in intact cells (see Section 3.7, below). This phenomenon reveals two details; the targeted domain of bilitranslocase is both extracellular and is critical for BSP and bilirubin transport functions.
This experimental evidence has been included in the set of physico-chemical constraints used to develop a topological model for the embedding of the bilitranslocase polypeptide into the membrane (Prof. Davor Juretic and Dr. Ana Lucin of the University of Split, Croatia; unpublished data). According to prediction, the 38 kDa protein is arranged into four transmembrane domains, with both N and C-terminal ends located intracellularly. This arrangement is not structurally sufficient to form a transport pore required for the observed functionality, therefore suggesting the existence of a bilitranslocase oligomeric state.
Antibody B
To challenge the derived topological model, which predicted a small extracellular domain (amino acids [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] placed at the putative infundibulum of the transport pore, a corresponding synthetic peptide was used to produce the polyclonal antibody B. Although possessing some specific distinctions [116] , this antibody displays most of the biological activities of antibody A (e.g. its inhibition of BSP and malvidin 3-glucoside uptake in HepG2 cells [148] ), and thus data obtained with antibody B builds upon earlier characterization of the primary structure of bilitranslocase, particularly in a region absent in the truncated clone, and later obtained by RACE-PCR of rat liver RNA. In addition, it supports the accuracy of the topological model for the membrane embedding of bilitranslocase.
Antibody C
A third antibody, antibody C, raised against a C-terminal region of the polypeptide chain, is currently under investigation. Preliminary data show that it displays the expected biological properties, including the specific inhibition of electrogenic BSP transport in rat liver plasma membrane vesicles (Sabina Passamonti, Michela Terdoslavich and Vladka Curin, unpublished data), again consistent with the expression and function of bilitranslocase as the translation product of an antisense transcript.
Bilitranslocase as a Bilirubin Transporter
Electrogenic BSP transport in plasma membrane vesicles is modulated by bilirubin in a number of kinetic assays, with bilirubin behaving as a competitive inhibitor [117] . In both plasma membrane vesicles from rat liver and microsomes from HepG2 cells, the K i of bilirubin was about 100 nM, showing no major functional differences between rodents and humans [117] .
Time-dependent inhibition of electrogenic BSP transport can be observed by pre-incubating rat liver plasma membrane vesicles with either antibody A [124] or antibody B [116] . In both cases, the rate constant of transport inhibition, observed at a given immunoglobulin concentration, is sensitive to bilirubin added to the preincubation mixture in a low nM range. In both cases, said protection effect is saturable with respect to bilirubin concentration, its halfmaximal value representing the dissociation constant, K d , of the bilirubin-bilitranslocase complex. Antibodies A and B interact with two distinct extra-membranous domains of the electrogenic BSP transporter, evidenced by their correspondingly distinct bilirubinbilitranslocase K d values, 2.2±0.3 nM and 0.33±0.01 nM, respectively. Additionally, nicotinic acid exerts protection against antibody A inhibition (K i =11.3±1.3 nM), but not versus antibody B [116] . These data shed light on the complex interaction of bilitranslocase with bilirubin. Two kinetically distinct binding sites are exposed at the cell surface, both facing the plasma. Their very high affinity for bilirubin suggests that bilitranslocase can successfully compete with albumin, which reversibly binds bilirubin in the blood [149] , resulting in the extremely low free bilirubin concentration (10 -7 M) of plasma [150] . Conversely, the competitive interaction of bilirubin with the BSP transport pore, presumably involving the bilitranslocase trans-membrane domain, suggests that bilirubin might be a bilitranslocase transport substrate. To test this hypothesis, a cellular uptake assay, using dilute solutions of albumin-free bilirubin, was set up. HepG2 cells were incubated in these solutions and the relative changes to pigment concentration in the medium throughout the uptake experiment were detected by thermal lens spectroscopy [151] , a highly sensitive technique with a limit of detection <2 nM for bilirubin. The uptake was found to be carriermediated, as it was blocked by a protein-modifying reagent and by nicotinic acid, thus ruling out passive diffusion. Antibody A strongly inhibited bilirubin uptake, showing that bilitranslocase was the carrier involved [117] .
Bilitranslocase as a Flavonoid Transporter
Similar cellular uptake tests in HepG2 were carried out in the presence of two flavonoids, the anthocyanin malvidin 3-glucoside [148] and the flavonol quercetin, uptake of the latter shown in Fig.  (3) . In both cases, uptake was inhibited by antibodies A and B, showing that bilitranslocase operates as a flavonoid-specific membrane transporter.
Expression of Bilitranslocase in Extra-Hepatic Tissues
Besides the liver, bilitranslocase has also been found to be expressed in the absorptive epithelia of the gastro-intestinal tract and the kidney.
The Gastric Epithelium
The morphological unit of the gastric epithelium is the gastric gland, namely a histological structure specialized in secreting hydrochloric acid, pepsinogen and mucus into the lumen [152] . However, the gland is similar to a typical absorptive epithelium, since it is composed of a single layer of cells resting on a basal membrane and in close contact with the peripheral vessels. By immunochemistry, bilitranslocase was found in the gastric epithelium [153] , specifically located in two of the most important cell types of the gastric glands, the mucus-secreting cells lining the mucosa, and in the acid-secreting parietal cells found deeper in the tubular glands [154] . Thus, it appeared that bilitranslocase might confer some absorptive properties to the stomach epithelium. This rather unexpected finding posed an intriguing question about the role of a bilirubin-specific membrane carrier in an environment where bilirubin is nutritionally irrelevant. An initial hypothesis suggested that gastric bilitranslocase was involved in the absorption of nicotinic acid, one of the vitamers of niacin (vitamin B3), the metabolic precursor of NAD + /NADH+H + . As such, nicotinic acid occurs at very low concentrations in food [155, 156] , and a high-affinity transporter might dramatically improve its extraction and absorption. Indeed, some evidence on subcellular fractions from gastric epithelia and on isolated rat stomachs indicate that bilitranslocase could accomplish such a function [157] . This hypothesis remains attractive, since a nicotinic acid-specific membrane carrier, such as the SMCT1 (sodium-monocarboxylate transporters, SLC5A8), is primarily expressed in the mucosa of the intestine epithelium [158, 159] . Fig. (3) . Uptake of quercetin into HepG2 cells and inhibition by bilitranslocase antibodies. This experiment was carried out as described in ref. [148] . HepG2 cells were grown to confluence in tissue culture flasks. Monolayers were pre-incubated in fresh cell culture medium without (circles) or with 0.24 g/ml of the following immunoglobulins: bovine immunoglobulins (providing a control condition, hexagons), or antibody A (triangles), or antibody B (squares). After 30 min, the cells were washed with phosphatebuffered saline solution and then 7 ml of the same solution containing 5 M quercetin were added. Samples of the medium were taken and analyzed at =375 nm ( =18.1 M-1 cm-1). All procedures were carried out at 37 °C. Control experiments of quercetin uptake at 0 °C (diamonds) were carried out under identical conditions. Each point represents the means±SEM of four experiments.
The occurence of bilitranslocase in the gastric epithelium also leads to a second relevant hypothesis, that the carrier might be involved in the absorption of dietary compounds, an ideal candidate being the anthocyanins because of their structural analogies with phthaleins (see above paragraph 3.4.1). Indeed, grape anthocyanins were found to be specific competitive inhibitors of bilitranslocase transport activity [114] , assigning to this carrier a role in the membrane transport of plant-derived food components.
The Selective Flavonoid Absorptive Properties of the Stomach
To test the absorptive properties of the stomach, a solution containing grape anthocyanins was administered into the ligated stomach of anesthetized rats. A few minutes later, anthocyanins appeared in plasma as intact molecules [148, [160] [161] [162] . It should be emphasized here that anthocyanins are glycosylated, water-soluble and rather bulky compounds (m.m.: 500), so that passive diffusion across the gastric epithelium is highly unlikely. Supporting this position is the case of the water-soluble drug YM758, structurally different from flavonoids, but with a comparable molecular weight. This compound is not absorbed into the stomach, but only into the intestine [163] , where it seems to be transported by members of the OATP family, possibly OATP1A2 [164] , OATP2B1 [165] , or OATP1B1, the latter recently found in the intestine [164] and responsible for YM758 uptake into the liver [166] . Thus, the gastric absorption of anthocyanins must be interpreted as carrier-mediated trans-cellular transport, with para-cellular absorption through the inter-cellular space highly unlikely, since the gastric epithelium provides an exceptionally impermeable barrier, preventing the diffusion of even ammonia and carbon monoxide, which are generally believed to freely diffuse across cell membranes [167] .
Similar and corroborating observations concerning anthocyanin uptake have been made in other laboratories [168] [169] [170] [171] [172] . Interestingly, slowing the rate of gastric emptying by co-administering phytic acid [173] or cream [174] increased anthocyanin absorption, again showing that the stomach is a significant site of absorption of these pigments.
The occurrence of anthocyanin absorption from the gastric lumen also explains the general pharmacokinetic features of orally administered anthocyanins: the maximal plasma concentration is attained within 0.5-2 hours after administration [175, 176] , which corresponds to the time required for emptying the stomach from a liquid content [177] . Gastric absorption is also postulated for explaining the bi-phasic plasma concentration curve of delphinidin 3-glucoside in rats, with the earliest plasma peak found only 15 min after oral administration [178] .
Gastric absorption has also been described for other flavonoids. Quercetin, but neither isoquercitrin (quercetin 3-O-glucoside) nor rutin (quercetin 3-O-rutinoside), was found to be absorbed from the stomach [179] . These data can be easily interpreted in the light that among them, only quercetin is a bilitranslocase substrate [115] . Similarly, the isoflavones genistein and daidzein, but not their glucosides, are absorbed from the rat stomach [180] . As mentioned above, neither genistein nor daidzein are bilitranslocase substrates. Clearly, either they are absorbed by passive diffusion or require another specific membrane carrier. A candidate might be one of the members of the organic anion transporter (OAT) family, since both genistein and daidzein are transported into Caco-2 cells by OAT [181] . This hypothesis implies the expression of some OAT isoforms in the stomach. The main sites of OAT expression are the kidney, the liver and the brain, though OAT2 has also been detected in the mouse stomach and intestine during development and postnatal days [182] . Other potential candidates are SMCT1 and especially SMCT2, which are expressed in the stomach mucosa [159, 183] . The flavone luteolin is a high-affinity inhibitor, and thus a potential transported substrate, of SMCT1 [91, 92] . Indeed, gastric uptake of the flavone baicalein and its glucuronide derivative baicalin has been described [184] , and also in this case SMCTs might be involved. In addition, these carriers are postulated to play a role in the gastric absorption of other non-flavonoid, dietary, watersoluble phenolic acids [185] [186] [187] [188] .
These data, though still fragmentary, confirm that the gastric epithelium displays unique and selective absorption properties, clearly dependent on the expression and substrate specificity of specific membrane carriers. An improved understanding of the selective absorptive functions of the stomach will offer new opportunities to exploit this segment of the digestive tract for the substrate-selective and well-timed delivery of orally administered drugs.
The Enteric Epithelium
In contrast to previous reports [153] , recent studies have revealed that bilitranslocase is also expressed at the intestinal epithelial level. Bilitranslocase was found in rat jejunum at the apical domain, but not at the basolateral membrane of enterocytes, as shown in Fig. (4) ; significantly, the protein is expressed only on the villi and in the uppermost Lieberkühn's crypts, in areas where the differentiation of enterocytes has been accomplished [189] . Caco-2 cells (deriving from a human colon carcinoma) express bilitranslocase as well, Fig. (5A) , and the uptake of BSP into these cells is strongly inhibited by anti-bilitranslocase antibodies, Fig. (5B) . Negative results in the preliminary study [153] were probably due to experimental limitations: the immunochemical analysis was done under exceedingly stringent conditions and was not accompanied by immunohistochemistry. These data are relevant, in that they pave the way to the understanding of the mechanism of the intestinal absorption of quercetin, which is still regarded as a passive diffusion step, albeit based on undemonstrated assumptions [68, 76] . Furthermore, this also explains why quercetin, but not its glucosides, (that are not bilitranslocase substrates [115] ), diffuses into the intestinal epithelial cells. Fig. (4) . Light pictomicrograph of rat enteric mucosa. A section of rat jejunum was fixed, paraffin embedded and immunostained with an antibilitranslocase antibody and an alkaline phosphatase-conjugated secondary antibody as described in ref. [154] . Strong positivity (black stain) is confined to the brush border membrane of epithelial cells on the villi. Magnification 40x. Courtesy of Dr. Vanessa Nicolin, University of Trieste.
The detection of bilitranslocase on the luminal surface of the intestinal epithelium also helps in understanding the mechanism of absorption of anthocyanins [175] , for which no other specific trans-porter has yet been reported. The possible role of glucose transporters has been previously ruled out on the basis that glucose fails to decrease cyanidin 3-glucoside absorption in both in vivo [190] and in vitro intestinal models [191] . Fig. (5) . A. Immunochemical identification of bilitranslocase in Caco-2 cells. The Western blot was carried out as described in ref. [116] . Samples (80 g proteins) were separated by SDS-PAGE and electroblotted on nitrocellulose membrane; the latter was incubated with 1.5 g/ml bilitranslocase antibody A and an alkaline phosphatase-conjugated secondary antibody and finally stained by the addition of bromochloroindolyl phosphate and nitroblue tetrazolium. Lane 1=erythrocyte ghosts (negative control); lane 2= Caco-2 cell lysate; lane 3=rat liver plasma membranes (positive control); lane 4=lysate of a human cell line (undisclosed); lane 5= HepG2 cell lysate; lane 6=electrophoretic mobility markers (molecular mass, kDa). B. Uptake of BSP into Caco-2 cell monolayers and inhibition by anti-sequence bilitranslocase antibodies. This experiment was carried out as described in ref. [147] . Caco-2 cells were grown to confluence in MEM-Eagle culture medium. Monolayers were pre-incubated in fresh cell culture medium without (circles) or with 0.24 g/ml of bilitranslocase antibody A (triangles) or antibody B (squares). After 30 min, the cells were washed with phosphatebuffered saline solution and then 7 ml of the same solution containing 24.6 M BSP was added. Samples of the medium were taken and analyzed in alkali at =580 nm ( =64 mM-1 cm-1). All procedures were carried out at 37 °C. Each point represents the means±SEM of four experiments.
In vivo, the uptake of cyanidin 3-glucoside was inhibited by quercetin 3-glucoside, suggesting that both types of flavonoids might share a common membrane transport system, as proposed by the authors [190] . A different interpretation of these results is possible by viewing bilitranslocase in the following context. Bilitranslocase-mediated uptake of cyanidin 3-glucoside was inhibited by the demonstrated occurrence of quercetin aglycone, itself resulting from the hydrolysis of quercetin 3-glucoside, both in the luminal compartment and into the intestinal tissue.
Various anthocyanins have been found to be absorbed by human intestinal cell (Caco-2) monolayers [192] . The extent of absorption into the serosal compartment, (faced by the basolateral domain of the enterocyte plasma membrane), was, however, in the range of as low as 3-4% of the administered dose. However, the data show a striking correlation between the extent of absorption for specific anthocyanins and the affinity of anthocyanins for bilitranslocase [114] .
Delphinidin 3-glucoside was the least absorbed compound, and it is the anthocyanidin monoglucoside with the lowest affinity for bilitranslocase (K i =8.6 M), while the most efficiently absorbed ones, peonidin 3-glucoside and malvidin 3-glucoside, are also the best bilitranslocase ligands (K i =1.8 and 1.4 M, respectively). The correlation continues when comparing the glycosylated derivatives of cyanidin, where cyanidin 3-glucoside better absorbed than cyanidin 3-galactoside, with the former a better bilitranslocase ligand (K i = 5.8 M) than the latter (K i =35 M).
In another more recent study [193] , the appearance of anthocyanins in the serosal compartment could not even be detected. In both this and the above-mentioned article, retention of anthocyanins into the cell monolayer was rather extensive, up to 60%, and was consistent with their anti-mitotic effect [194] . Thus, anthocyanins might enter Caco-2 cells via bilitranslocase, but would find a barrier for their diffusion across the basolateral (serosal) side of the cell membrane. These data help explain the low reported bioavailability of anthocyanins, while posing new questions. Firstly, basolateral membrane carriers, facilitating the diffusion of absorbed macronutrients, examples being GLUT2 [75] , amino acid transporters [102] and others mentioned above in section 2.3.5, seem to play no significant role in the cellular efflux of anthocyanins. Secondly, primary active transporters, such as MRP1, MRP3, MRP4 and MRP5 [58] , also seem uninvolved, though their role as flavonoid efflux transporters has been demonstrated elsewhere [58] .
Different mechanisms for the escape of intracellular anthocyanins from the enteric epithelium into the blood need to be taken in consideration. A very attractive possibility is that already highlighted for quercetin, which is not transported directly into the mesenteric portal capillaries, but rather into the lymphatic system [195] . This would imply that quercetin, and perhaps also anthocyanins, might leave the intestinal cells in association with lipoproteins. This hypothesis is supported by the observation that dietary fat helps improve quercetin absorption [196] . Indeed, the intestine is an important site of synthesis of lipoproteins, even in the fasting state [197, 198] . Specific interactions of flavonoids with the various apolipoproteins synthesized in the enterocytes [199] require further investigation.
The Renal Epithelium
In the kidney, bilitranslocase was detected in the basolateral domain of proximal tubular cells by immuno-histochemistry [200] . Electrogenic BSP transport activity in basolateral plasma membrane vesicles is inhibited by anti-bilitranslocase antibodies, whether raised against the purified whole protein [200] or against a segment of its primary sequence [162] . The activity is also competitively inhibited by malvidin 3-glucoside (K i =4.8 M), taken as a representative anthocyanin. These findings point to a role of bilitranslocase in promoting the facilitated diffusion of anthocyanins from the blood into the kidney tubular cells. Indeed, studying the tissue distribution of anthocyanins 10 minutes after their administration into the stomach of anaesthetized rats [162] , it was found that while the plasma and liver concentrations were at an apparent equilibrium, the anthocyanin concentration in the kidney was about 3 times higher than in plasma. Very striking was the finding that methyla-tion was the main short-term metabolic modification of anthocyanins into the kidney [162] . These observations contribute to advancing knowledge about the urinary excretion of anthocyanins [170, [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] . These might undergo glomerular filtration, but the occurrence of bilitranslocase at the basolateral domain of proximal tubular cells together with the evidence of methylation of delphinidin 3-glucoside to petunidin 3-glucoside supports the position that anthocyanins in the blood can be taken up and undergo metabolism within the kidney. More research is needed to better characterize the mechanism(s) underlying anthocyanin uptake into the kidney tubular cells and their efflux into the kidney tubule.
BROMOSULFOPHTHALEIN: A FADING ROLE IN CLINICAL DIAGNOSTICS, AN INSPIRING ROLE IN NUTRITION AND PLANT BIOLOGY
BSP is a synthetic, polyphenolic, pH-indicator dye used to assess liver function [213] [214] [215] [216] . Elimination of BSP by the liver represents a paradigm of xenobiotic detoxification in animal organisms; furthermore, it lends itself to comparison with plant-specific detoxification pathways [217] [218] [219] . Identifying biochemical mechanisms common to both plant and animal kingdoms increases the rate of discovery and characterization of otherwise elusive features of biology [220, 221] . The investigation of flavonoid membrane transport in the plant subcellular compartments, discussed later in Section 5, has rejuvenated some experimental methods characterizing BSP toxicology in animal cells [222, 223] . The pharmacokinetics of BSP is summarized below. It is noteworthy that cellular BSP influx and efflux are catalyzed by membrane transporters, later found to interact with and transport flavonoids.
Pharmacokinetics of BSP
Following its intravenous injection, BSP is distributed to all tissues of the body, but its metabolism is confined to the liver, where it is taken up via various organic anion transporters, including OATP1B1 and OATP1B3 [224] , OAT2 and OAT3 [225] , and bilitranslocase [110, 117] . In the cytoplasm, BSP is bound by glutathione S-transferase enzymes (GSTs) (EC 2.5.1.18), such as GSTA1-1 [226] and GSTP1-1 [227] , which play the role of ligandins [228] . Class GSTs catalyze the mono-glutathione conjugation of BSP to yield BSP-GS [229, 230] ; subunit analysis indicated that GSTM1-1 is the prevailing hepatic isoform [231] . Finally, BSP-GS is excreted into the bile via MRP2 (ABCC2) [232] . The rate at which it disappears from the circulation following intravenous injection is strictly related to the liver functional reserve [214] ; alterations of different kinetic parameters of the BSP clearance test can also selectively reveal defects of the plasma-to-liver and liver-tobile transport, respectively [216] . Though extensively used in experimental and clinical hepatology, in clinical practice this test has been replaced by a similar one, based on the safer dye alternative, indocyanine green [233] .
Pharmacokinetics of BSP and its Interplay with Bilirubin
The tetrapyrrole bilirubin is the final product of the ubiquitous catabolism of heme, the majority derived from haemoglobin [234] ; it is excreted by the liver into the bile, to which it confers a typical yellow-orange color. Bilirubin pharmacokinetics is similar to that of BSP and indocyanine green [235] , and their hepatic detoxification pathways overlap at multiple steps. Being a hydrophobic compound, bilirubin occurs in plasma as a reversible complex with serum albumin [149] . It is rapidly transported into the liver via a carrier-mediated mechanism, shared with both BSP and indocyanine green [235] ; then, it binds to a class GST in the cytosol [236] , acting as an intracellular storage system (ligandin) [237] . The complex of bilirubin with GSTA1-1 and GSTA2-2 is then transferred to the microsomal compartment [238] that expresses uridine 5'-diphosphate-glucuronosyltransferase 1A1 (UGT1A1) [239] , able to catalyze the formation of bilirubin di-glucuronide (EC 2.4.1.17). The latter metabolite is then excreted into the bile via MRP2 [232] .
Bilirubin Clearance and its Interplay with Flavonoids
In principle, if flavonoids interfere with BSP binding to enzymes and transporters, they might also interfere with bilirubin metabolism. For example, the multispecific primary active membrane transporter, MRP2, which catalyses the overall rate-limiting step of hepatic bilirubin elimination, is inhibited by various flavonoids, such as genistein [240] , flavopiridol [241, 242] , quercetin metabolites [243, 244] and flavones [245] .
The inhibition of glutathione transferase activity by anthocyanins is also noteworthy [246] , though it is not known if this involves the ligandin activity with respect to bilirubin. More interesting is the specific inhibition of UGT1A1 by the synthetic flavone flavoxate, resulting in hyperbilirubinemia [247] . Natural flavonoids that undergo hepatic glucuronidation, such as prunetin [248] , eupatilin [249] and silibinin [250] , may also induce jaundice, if ingested in high quantity, as confirmed in a silibinin clinical trial [251] . Thus, the inhibition of bilitranslocase transport activity by flavonoids, as well as those of other proposed bilirubin carriers such as OATP1A1 [101] , is in line with the view that flavonoids, in part, mimic bilirubin pharmacokinetics.
Bilirubin as an Endogenous Antioxidant
The efficient hepatic disposition of bilirubin together with severe bilirubin-induced encephalopathy observed in jaundiced newborns [252] have promoted the viewpoint that bilirubin is a toxic, lipophilic, waste compound, and something solely to be eliminated. However, questions remain concerning the survival and fitness advantages of animals expressing biliverdin reductase [118] , catalyzing bilirubin production from biliverdin, which is itself a hydrophilic tetrapyrrole that can be eliminated unmodified, in both bile [253] and urine [254] . The discovery of the antioxidant property of bilirubin [255] contributed to challenge the viewpoint of bilirubin as a mere toxic catabolite [256] . Bilirubin, whose production in human adults amounts to 250-300 mg/day [257] , is now seen as a useful endogenous antioxidant [258] [259] [260] , thereby allowing natural selection to logically explain the otherwise superfluous enzymatic step in heme catabolism, ending with bilirubin instead of biliverdin. Indeed, the oxidation of bilirubin to biliverdin, caused by excessive cellular reactive oxygen species, can be reversed by NADPHdependent biliverdin reductase [261] , making the bilirubin/ biliverdin cycle quite similar to that of glutathione.
Dietary Flavonoids as Enhancers of Endogenous Antioxidants
Given the mutual metabolic interference between flavonoids and bilirubin, it can be speculated that the transient increase in antioxidant capacity of plasma following ingestion of flavonoids [262] might be, in part, ascribed to a transient, and reversible decrease of bilirubin clearance by the liver, the result being a very small increase of basal bilirubinemia. In fact, bearers of Gilbert's syndrome, a hereditary condition characterized by mild and intermittent jaundice, show a decreased risk of cardiovascular diseases in comparison to normo-bilirubinemic populations [263] .
BILITRANSLOCASE AS A FLAVONOID TRANSPORTER IN PLANTS 5.1. Flavonoid Synthesis and Transport in Plants
As mentioned above, flavonoids are secondary metabolites unique to plants, where they play important functions in a multitude of processes, diverse as UV protection, defense against several biotic and abiotic stresses, normal growth and development, and pigmentation of the reproductive organs and their resulting fruits, essential for attracting pollinators and seed-dispersers [264] [265] [266] . Due to the amazing variety of forms and functions, the pathway responsible for the synthesis of flavonoids has been extensively studied in numerous plant species [2, 267, 268] . Progress in this field has elucidated most of the enzymes involved, along with the corresponding genes and the signalling pathways which regulate the expression of the biosynthetic genes [269] .
Biosynthetic Pathway of Flavonoids
It was demonstrated that flavonoids are synthesized, via the phenylpropanoid pathway, by cytosolic multienzyme complexes at the cytoplasmic surface of the endoplasmic reticulum (ER) [270, 271] . Furthermore, some enzymes, belonging to flavonoid metabolism, were also reported to be co-localized at the ER, tonoplast, nucleus, secondary cell wall, and even plastid [272, 273] . The main branches of the pathway lead to the formation of anthocyanins, flavonols, flavan-3-ol monomers (catechins) and proanthocyanidins (PAs), as shown in Fig. (6) [268, 274] . Finally, modifications at single or multiple positions of flavonoid molecules via hydroxylation, methylation, acylation, or glycosylation reactions provide unique features and characteristics to most of the currently known flavonoids.
Mechanisms of Intracellular Flavonoid Transport
Flavonoid-derived compounds are delivered from the sites of synthesis to different locations. The majority of flavonoids accumulate in vacuolar compartments, whereas others may be secreted and incorporated into the cell wall. Similarly, at the organ level, flavonoids are accumulated by the cells belonging to the outermost peripheral tissues, mainly in the tegument or hypodermal cell layers. In this case, it has to be noted that flavonoid precursors could also be synthesized at the inner parenchymatic tissues and then translocated to the peripheral layers for their proper accumulation, by a mechanism similar to that proposed for phenylpropanoids, terpenoids and alkaloids, as well for their biosynthetic intermediates [275] . The intercellular translocation of secondary metabolites is likely to occur by active transport processes, but the specific transporters involved to have not been satisfactorily identified.
Despite understanding the major steps involved in the flavonoid biosynthetic pathway, many unanswered questions still remain regarding the mechanism(s) by which the flavonoid end-products are properly sorted and transported into the diverse intracellular compartments. In particular, it was suggested that the flavonoids are escorted from the cytoplasmic face of the endoplasmic reticulum, (the site of their biosynthesis), to the vacuolar membrane, following two different pathways [265] , shown in the scheme of Fig. (7A) . In the first mechanism, it was assumed that flavonoid-specific GSTs carry flavonoids to the vacuole, via a non-covalent (ligandin) activity [276] . Alternatively, the second mechanism requires a complex vesicle-trafficking network, possibly involving the Golgi apparatus [274, 277, 278] . In the endoplasmic reticulum-to-vacuole vesicular transport model proposed for proanthocyanidin and anthocyanin accumulation [278, 279] , specific transporters are present at the Golgi and/or endoplasmic reticulum membranes, to upload flavonoids inside vesicles. Then, endoplasmic reticulum-or Golgi-derived vesicles, containing the flavonoid precursors, could reach the vacuolar membrane and fuse with the tonoplast.
Furthermore, flavonoid transport across the vacuolar membrane requires transporters capable of moving them inside the compartment. Currently, several different vacuolar uptake mechanisms have been proposed, which could be species-specific or flavonoid endproducts-specific, relying on conjugated moieties such as sugars or acyl residues, and are sensitive to phenological stage, organ and tissue localization, and environmental factors [280, 281] . Thus, an individual species could possess a diverse array of coexisting transport mechanisms. Specific transporters of flavonoids were reported in several species, such as maize (Zea mays), petunia (Petunia hybrida), Arabidopsis thaliana and grapevine (Vitis vinifera) [265] . These carriers are mainly characterized by two different kinds of energization: direct activation by hydrolysis of ATP, (primary active transport), or secondary activation by using trans-membrane proton gradients, (secondary active transport). The ATP-binding cassette (ABC) proteins were shown to be responsible for vacuolar sequestration or external secretion of many substrates including flavonoids, chlorophyll catabolites and xenobiotic molecules [220, 282, 283] . In particular, these compounds, after their conjugation with glutathione (GSH) catalyzed by GSTs, are translocated by the glutathione S-conjugate (GS-X) pumps, a subclass of the ABC-type transporters [284] . The GS-X pumps, recently classified as multidrug resistance-associated proteins (MRPs), were also suggested to be involved in the specific uptake of exogenous glycosylated flavonoids and xenobiotic aglycones in many plant species [285, 286] .
In contrast, the second vacuolar uptake mechanism requires a secondary energized proton/flavonoid antiporter, as demonstrated by vacuolar uptake of acyl-or sugar-conjugated flavonoids [286] [287] [288] . This mechanism was suggested to be mediated by multidrug and toxic extrusion (MATE) proteins, as reported for PAs in A. thaliana [289] and for saponarin in barley (Hordeum vulgare) [290] .
An emerging view suggests that differences in the moieties attached to the flavonoid molecule may determine the specific type of transport mechanism. Glycosylated flavonoids would be preferentially transported by secondary active MATE-like antiporters, while the glutathione-linked flavonoids would be primarily recognized by ABC proteins, in particular MRP [282] , as outlined in Fig.  (7A) .
Bilitranslocase Homologues in Plants
In agreement with the above postulated mechanisms for multiple, flavonoid-specific transport, recent findings have described the presence of a bilitranslocase homologue in plant organs, including carnation petals [116] and grape berries [291] . Its occurrence could already be hypothesized, considering that anthocyanins and some flavonols are efficiently transported by the mammalian bilitranslocase, and that BSP shares structural similarities with flavonoids. Additionally, other putative substrates containing bilin moieties are present in plants, such as chlorophyll degradation products, the chromophore of phytochrome, or the photosynthetic pigments (i.e. phycocyanobilins) in red algae.
Bilitranslocase Homologue in Carnation Petals
The first bilitranslocase homologue was found in carnation (Dianthus caryophyllus L.) petals. There, a protein of ca. 37 kDa was identified in both the plasmalemma and tonoplast, by immunochemical means, using two antibodies raised against different sequences of mammalian bilitranslocase (antibodies A and B) [116] . Immunodecoration staining allowed localization of this homologue to the peripheral zone of the epidermal cells. Using the electrogenic BSP transport assay (see Section 3.1, above), its transport activity was also demonstrated in microsomal vesicles obtained from carnation petals. This carrier appears to be involved in anthocyanin transport, because BSP transport was competitively inhibited by cyanidin 3-glucoside (K i = 51.6 m) and, mainly non-competitively, by cyanidin (K i = 88.3 m). Analogue inhibition was found in the presence of the anti-bilitranslocase antibodies, confirming structural homology between bilitranslocase and the plant carrier.
Bilitranslocase Homologue in Grape Berries
These findings were further confirmed in the flavonoid-rich berry organ of grape (V. vinifera), from both red [291] and white cultivars 2 . The grape berry represents a model organ, due to its high content of pigments, tissue-specific distribution pattern, and the well-known pathway for the synthesis of phenolic substances during grape berry development.
Immunohistochemical analysis confirmed the presence of the bilitranslocase homologue in the tegumental cells, where the highest accumulation of flavonoids takes place. At a subcellular level, the cross-reactivity with anti-bilitranslocase antibodies could be detected at the cell wall and the nearby vacuolar compartment, as previously shown in carnation. In addition, the presence of a strong signal inside the cell lumen suggests an involvement of the bilitranslocase homologue in pigment precipitation, possibly leading to the formation of AVIs (anthocyanic vacuolar inclusions). This mechanism causes pigment accumulation and prevents their lytic degradation by vacuolar enzymes [292] . This phenomenon may explain anthocyanin accumulation even in a senescent tissue such as mature berry skin, which would otherwise not be able to maintain adequate membrane energization and active transport [293] .
Immunohistochemical evidence also suggests the presence of a carrier in the vascular bundles of the berry pulp [291] . This observation is consistent with the participation of the bilitranslocase homologue in the transport of colorless flavonoids. Accordingly, it is known that the biosynthesis of flavonoid precursors also takes place in pulp tissues, although to a lesser extent [294] , and such intermediates to require translocation to the peripheral tegumental tissue for further glycosylation and/or accumulation. Hence, the bilitranslocase homologue could play a role in phloematic (longdistance) translocation of flavonoids, analogous to the mechanism already proposed for phenylpropanoids, terpenoids and alkaloids [275] , Fig. (7B) . Fig. (7) . A. Scheme of subcellular transport of flavonoids in the plant cell. Flavonoids are synthesized in the cytoplasm, where they may or may not be conjugated with glutathione (GSH) through a reaction catalysed by glutathione S-transferases (GSTs). One suggested mechanism of transport involves vesicle trafficking from the endoplasmic reticulum and Golgi apparatus, as indicated by dark circles. Once vesicles fuse with the tonoplast membrane, they pour their content into the vacuole, where they may be associated with anthocyanic vacuolar inclusions (AVIs), which are darkly pigmented inclusions of anthocyanins and protein found inside vacuoles. The main transporters localized in the vacuole and plasma membranes are the ATP-binding cassette proteins (ABCs), the multidrug and toxic compound extrusion (MATE) proteins, along with the bilitranslocasehomologue (BTL). B. Flavonoid accumulation/translocation and BTLhomologue localization in the main tissues of grape berry fruit. Flavonoid end-products are mainly accumulated in tegumental layers of the berry skin and seed, whereas their precursors could be synthesized in other cell types and translocated by vascular tissues (dark shading indicates flavonoids present in the tissue). Immunochemical detection of BTL homologue indicates its localization at the tegumental tissues of skin pericarp and seed, along with the vascular bundles of the pulp (BTL, representing the abbreviation for BTL-homologue protein).
Similarly to red berries, immunohistochemical assays have provided evidence for the presence of the bilitranslocase homologue in both the berry pulp and skin of white cultivars 3 . This result is intriguing, as white berries accumulate only trace amounts of anthocyanins in the tegumental tissues, where other colorless flavonoids are instead synthesized during maturation. In agreement, with the above-mentioned results, a stronger signal was also found in vascular bundles of the pulp, in comparison to the skin. Taken together, these data demonstrate that the bilitranslocase homologue is selectively detectable only in tissues that are directly involved in flavonoid synthesis or their translocation, in agreement with previous findings obtained in carnation where parenchymatic cells exhibited no immunochemical staining [116] .
Additionally, the expression profile of the bilitranslocase homologue was investigated during berry maturation; a membrane protein of ca. 30 kDa was evidenced in both red berry pulp and skin, starting from véraison stage until the maturation [291] . This profile resembles the pattern of anthocyanin accumulation during maturation, and protein expression increased in the skin up to the final maturation stage, closely following pigment accumulation, while in the pulp it exhibited a bell-shaped pattern, mimicking the synthesis of anthocyanin precursors and/or colorless flavonoids (PAs), which are known to be accumulated earlier than anthocyanins [295] .
Further linkage between flavonoid accumulation and the bilitranslocase homologue was evidenced by the observation that waters deprivation could induce both an increase in flavonoid accumulation and enhanced carrier expression, in grape berries [291] .
The phloem localization of the bilitranslocase homologue tantalizingly suggests this protein contributes to the long-distance transport of secondary metabolites, which undergoes a significant change at the onset of berry véraison [296] . In fleshy fruits, like grape berry, sap flow exhibits a shift from xylematic to phloematic transport, due to the decrease of the hydrostatic potential [297] . In addition, transport efficiency is decreased during maturation by changes to phloem unloading, switching from asymplastic (through the plasmodesmata) to an apoplastic, (across the plasma membrane and the apoplasm) pathway [298] . These results support the hypothesis for the co-existence of several transport modalities, depending on the physiological conditions and tissue, to compensate for impaired transport efficiency during the period corresponding to the highest accumulation of flavonoids.
Lastly, electrogenic BSP transport activity in microsomal vesicles obtained from grape berry pulp was also demonstrated. Again, the recovered grapevine transporter shared some biochemical and kinetic characteristics with both mammalian bilitranslocase and the carnation carrier. A similar affinity value (K m = 2.39 M) was obtained, and electrogenic BSP transport activity could again be inhibited by an anti-sequence bilitranslocase antibody. In addition, quercetin, a colorless flavonoid compound, also naturally occurring in grape berry, caused competitive inhibition. These data further suggest an involvement of the carrier in flavonoid transport in grape berries, and extending its possible substrates to the non-pigmented flavonoids.
CONCLUSIONS
The membrane transport of flavonoids is a fundamental part of their bioavailability in both plant and animal organisms, and current knowledge suggests the involvement of both ATP-dependent pumps and ATP-independent transporters. Bilitranslocase, among the latter, operates as a uniporter, with proven functionally as a membrane transporter, catalyzing the electrogenic transport of BSP, a structural mimetic of flavonoids. Anti-sequence bilitranslocase antibodies have been used to examine the tissue localization and
